1.Levi-Montalcini, R. The nerve growth factor: thirty-five yeras later. EMBO J. 1987;6:1145–1154.
2.Tongiorgi, E. Activity-dependent expression of brain-derived neurotrophic factor in dendrites: facts and open questions. Neurosci Res. 2008;61:335–346.
3.Hu, Y, Russek, SJ. BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation. J Neurochem. 2008;105:1–17.
4.Lu, B, Pang, PT, Woo, NH. The yin and yang of neurotrophin action. Nat Rev Neurosci. 2005;6:603–614.
5.Bekinschtein, P, Cammarota, M, Izquierdo, I, Medina, JH. BDNF and memory formation and storage. Neuroscientist. 2008;14:147–156.
6.Carvalho, AL, Caldeira, MV, Santos, SO, Duarte, CB. Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br J Pharmacol. 2008;153(suppl 1):S310–S324.
7.Berton, O, McClung, CA, DiLeone, RJ, et al.Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006;311:864–868.
8.Takahashi, T, Suzuki, M, Tsunoda, M, et al.The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1236–1242.
9.Pezawas, L, Meyer-Lindenberg, A, Goldman, AL, et al.Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry. 2008;13:709–716.
10.Martinowich, K, Lu, B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology. 2008;33:73–83.
11.Galloway, EM, Woo, NH, Lu, B. Persistent neural activity in the prefrontal cortex: a mechanism by which BDNF regulates working memory? Prog Brain Res. 2008;169:251–266.
12.Kerschensteiner, M, Stadelmann, C, Deohant, G, Wekerle, H, Hohlfeld, R. Neurotrophic cross-talk between the nervous and immune systems: Implications for neurological diseases. Ann Neurol. 2003;53:292–304.
13.Santarelli, L, Saxe, M, Gross, C, et al.Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003;301:805–809.
14.Schmidt, HD, Duman, RS. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol. 2007;18:391–418.
15.Brunoni, AR, Lopes, M, Fregni, F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008 Aug 28:1–12. [Epub ahead of print].
16.Post, RM. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res. 2007;41:979–990.
17.Groves, JO. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry. 2007;12:1079–1088.
18.Kozisek, ME, Middlemas, D, Bylund, DB. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther. 2008;117:30–51.
19.Castrén, E, Võikar, V, Rantamäki, T. Role of neurotrophic factors in depression. Curr Opin Pharmacol. 2007;7:18–21.
20.Martinowich, K, Manji, H, Lu, B. New insights into BDNF function in depression and anxiety. Nature Neuroscience. 2007;10:1089–1093.
21.Egan, MF, Kojima, M, Callicott, JH, et al.The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112:257–269.
22.Chen, ZY, Patel, PD, Sant, G, et al.Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci. 2004;24:4401–4411.
23.Chen, ZY, Ieraci, A, Teng, H, et al.Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. J Neurosci. 2005;25:6156–6166.
24.Chen, ZY, Jing, DQ, Bath, KG, et al.Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science. 2006;314:140–143.
25.Dempster, E, Toulopoulou, T, McDonald, C, et al.Association between BDNF Val(66)Met genotype and episodic memory. Am J Med Genet B Neuropsychiatr Genet. 2005;134B:73–75.
26.Miyajima, F, Ollier, W, Mayes, A, et al.Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes Brain Behav. 2008;7:411–417.
27.Goldberg, TE, Iudicello, J, Russo, C, et al.BDNF Val66Met polymorphism significantly affects d' in verbal recognition memory at short and long delays. Biol Psychol. 2008;77:20–24.
28.Ho, BC, Milev, P, O'Leary, DS, Librant, A, Andreasen, NC, Wassink, TH. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry. 2006;63:731–740.
29.Pezawas, L, Verchinski, BA, Mattay, VS, et al.The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci. 2004;24:10099–10102.
30.Szeszko, PR, Lipsky, R, Mentschel, C, et al.Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry. 2005;10:631–636.
31.Bueller, JA, Aftab, M, Sen, S, et al.BDNF val(66) met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry. 2006;59:812–815.
32.Sublette, ME, Baca-Garcia, E, Parsey, RV, et al.Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1652–1655.
33.Takahashi, T, Suzuki, M, Tsunoda, M, et al.Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neurosci Lett. 2008;435:34–39.
34.Chepenik, LG, Fredericks, C, Papademetris, X, et al.Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology. 2008 Aug 13. [Epub ahead of print].
35.Hariri, AR, Goldberg, TE, Mattay, VS, et al.Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci. 2003;23:6690–6694.
36.Montag, C, Reuter, M, Newport, B, et al.The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study. Neuroimage. 2008;42:1554–1559.
37.Stern, AH, Savostyanova, AA, Goldman, A, et al.Impact of the brain-derived neurotrophic factor val66met polymorphism on levels of hippocampal n-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 tesla. Biol Psychiatry. In press.
38.Taylor, WD, Züchner, S, McQuoid, DR, et al.The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression. Am J Geriatr Psychiatry. 2008;16:263–271.
39.Frodl, T, Schuele, C, Schmitt, G, et al.Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry. 2007;64:410–416.
40.Frey, BN, Walss-Bass, C, Stanley, JA, et al.Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder. Neuroreport. 2007;18:1567–1570.
41.Agartz, I, Sedvall, GC, Terenius, L, et al.BDNF gene variants and brain morphology in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:513–523.
42.Ho, BC, Andreasen, NC, Dawson, JD, et al.Association between brain-derived neurotrophic factor val66met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry. 2007;164:1890–1899.
43.Nemoto, K, Ohnishi, T, Mori, T, et al.The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett. 2006;397:25–29.
44.Hemmings, SM, Kinnear, CJ, Van der merwe, L, et al.Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD). World J Biol Psychiatry. 2008;9:126–134.
45.Fan, J, Sklar, P. Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism. Novartis Found Symp. 2008;289:60–72.
46.Chen, L, Lawlor, DA, Lewis, SJ, et al.Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:814–821.
47.Joffe, RT, Gatt, JM, Kemp, AH, et al.Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: Implications for depressive illness. Hum Brain Mapp. 2008 Jun 11. [Epub ahead of print].
48.Cirulli, F, Francia, N, Berry, A, Aloe, L, Alleva, E, Suomi, SJ. Early life stress as a risk factor for mental health: Role of neurotrophins from rodents to non-human primates. Neurosci Biobehav Rev. 2008 Sep 4. [Epub ahead of print].
49.Uys, JDK, Marais, L, Faure, J, et al.Developmental trauma is associated with behavioral hyperarousal, altered HPA axis activity, and decreased hippocampal neurotrophin expression in the adult rat. In: Yehuda, R, ed. Psychobiology of Posttraumatic Stress Disorder: A Decade of Progress (Annals of the New York Academy of Sciences). 2006;1071:542–546.
50.Faure, J, Uys, JD, Marais, L, Stein, DJ, Daniels, WM. Early maternal separation alters the response to traumatization: resulting in increased levels of hippocampal neurotrophic factors. Metab Brain Dis. 2007;22:183–195.
51.Lu, B, Martinowich, K. Cell biology of BDNF and its relevance to schizophrenia. Novartis Found Symp. 2008;289:119–129.
52.Savitz, J, van der Merwe, L, Stein, DJ, Solms, M, Ramesar, R. Genotype and childhood sexual trauma moderate neurocognitive performance: a possible role for brain-derived neurotrophic factor and apolipoprotein E variants. Biol Psychiatry. 2007;62:391–399.
53.McClung, CA, Nestler, EJ. Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology. 2008;33:3–17.
54.Citri, A, Malenka, RC. Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology. 2008;33:18–41.
55.Mössner, R, Mikova, O, Koutsilieri, E, et al.Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry. 2007;8:141–174.
56.Schulte-Herbrüggen, O, Braun, A, Rochlitzer, S, Jockers-Scherübl, MC, Hellweg, R. Neurotrophic factors—a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases? Current Medicinal Chemistry. 2007;14:2318–2329.
57.Mocchetti, I, Brown, M. Targeting neurotrophin receptors in the central nervous system. CNS Neurol Disord Drug Targets. 2008;7:71–82.
58.Rantamäki, T, Castrén, E. Targeting TrkB neurotrophin receptor to treat depression. Expert Opin Ther Targets. 2008;12:705–715.
59.Kalra, S, Genge, A, Arnold, DL. A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:22–26.
60.Scharfman, HE, Hen, R. Is more neurogenesis always better? Science. 2007;315:336–338.